Call For Free Chicken Pox Vaccine
Call For Free Chicken Pox Vaccine
New Zealand health experts are today calling for the vaccine to protect children from Varicella-Zoster Virus - which causes chicken pox in children and shingles in adults – to be made free on New Zealand’s National Immunisation Schedule (NIS).
This is the recommendation of a study being presented at the 2014 Australian Society for Infectious Diseases (ASID) Meeting taking place in Adelaide from 26-29 March.
Varicella is a very common childhood condition and hospitalisations frequently occur for bacterial super-infection. The study being presented at ASID looked at the number of hospitalisations from varicella and post-varicella complications, and found the average age of those admitted to be 2.4 years. Almost a fifth of cases experienced ongoing problems upon discharge.
Maori and Pacific Island (PI) children accounted for 74% of admissions.
“Varicella is associated with significant morbidity. Maori and PI children are over-represented. This surveillance gives support for inclusion of varicella vaccine in the NZ NIS,” the researchers conclude.
OTHER LEAD STORIES ON NEW ZEALAND
Failing our children? Children's hospitals underfunded to stave off superbugs
Australia and New Zealand’s children’s hospitals lack resources to properly implement measures to control antibiotic resistance, and fare worse than adult hospitals, a study being released at the Australasian Society for Infectious Diseases (ASID) Meeting shows.
The spread of resistance to antibiotics has been agreed by health experts and politicians to be one of the greatest threats to human health in the modern age. Last year, David Looke, President of ASID and others warned of the coming of a new ‘Red Plague’ stating “Without intervention, many of the greatest advances in the practice of medicine — such as transplantation, joint replacement surgery or critical care medicine — will be under significant threat.”
“Without a coordinated effort at government level across all human and animal health care sectors, we are likely doomed to failure,” they warned.
In this study, children’s hospitals and large hospitals
with paediatric patients in every state and territory in
Australia and New Zealand were surveyed. Only half had a
dedicated paediatric Antimicrobial Stewardship (AMS) team.
While 71% hospitals had an AMS pharmacist, only 29% had
funding for a permanent paediatric AMS pharmacist. Only 14%
hospitals had dedicated funding for medical staff for
• All hospitals had empirical antibiotic guidelines and of those with oncology services 83% had febrile neutropenia guidelines. However, the majority did not have anti-fungal, surgical prophylaxis, intensive care or neonatal guidelines.
• There was a paucity of AMS education with no education for senior medical staff at all and 29% hospitals having no education for any staff.
• All hospitals had restricted drugs but only 29% hospitals had electronic approval systems.
• Auditing methods differed widely between hospitals but in the majority it was ad hoc, with results fed back in an untargeted way.
• The commonest perceived barriers to successful AMS included lack of education (79%) and of dedicated pharmacy (57%) and medical (50%) resources.
In 2013 Australasian children’s
hospitals have implemented some activities, but the majority
are lacking resources. Overall AMS is stronger in
predominantly adult hospitals, but paediatrics is often not
included, the study concludes.
• Read the antibiotic use press release
• Read the abstract on the national antimicrobial prescribing survey
• Read the abstract on factors underpinning antibiotic use
• Read the abstract on antibiotic resistance in New Zealand
Antibiotic ointments: No longer working in New Zealand?
New Zealand has high rates of Staphylococcus aureus skin infections, with subsequent high reported usage of topical antimicrobials. Overuse of topical fusidic acid (an antibiotic applied to the skin) is contributing to rapidly growing antibiotic resistance, with over 30% resistance to, one of the highest rates of resistance to topical antimicrobials in the world. “Improved regulation on the use of topical fusidic acid is urgently warranted,” experts say.
• Read the abstract on fusidic acid
Disease inequality in New Zealand:
Infectious disease inequality in New Zealand’s
population is continuing. “Maori and Pacific children in
NZ have a disproportionately high risk of (hospital)
admission with infection compared to New Zealand children of
European ethnicity, consistent with that observed in
Aboriginal children in Australia.”
• Read the New Zealand press release
• Read the abstract on childhood hospitalisations in New Zealand
streptococcal and staphylococcal disease are well above the
level seen in other developed countries. The incidence is
highest in the over 75-year age group, and in Pacific
Peoples, with the incidence in Pacific Peoples almost seven
times higher than in New Zealanders of European ethnicity.
“The increase in S. aureus SSTIs, coupled with the
observed demographic disparities, is of considerable
concern. Future work should aim to reduce this disturbing
• Read the abstract on S. aureus in New Zealand